Product Liability

July 10, 2015

Zimmer Persona Artificial Knees Under Fire

There have been many reports of loosening and other failure problems with the Zimmer Persona artificial knee replacements.

According to sources, more than 11,600 of the “personalized” artificial knee components have been recalled less than three years after the novel design was introduced.

FDA Warning and Class 2 Recall

July 9, 2015

Texas Transvaginal Mesh Injury Settlement

by Dr. Shezad Malik

The massive transvaginal mesh injury lawsuits has been slowly winding its way through both the federal and state court system, over the past 4-5 years. The unwieldy personal injury and defective product liability litigation, which now by some estimates tops 100,000 filed lawsuits by injured and affected women, has been painstakingly slow.

The is a silver lining to the litigation. Recently, Medtronic’s Covidien unit agreed to settle more than 11,000 transvaginal mesh lawsuits filed by women who experienced serious and severe complications with the products.

What is Transvaginal Mesh and why is it Dangerous?

May 7, 2015

Texas Attorney Explains the Link Between Zofran and Birth Defects

by Dr. Shezad Malik

Zofran, is an anti-nausea medication that is commonly prescribed for post surgical, chemotherapy and morning sickness patients over the past 20 years. According to experts, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children.

GlaxoSmithKline Allegations

Patients have blamed GlaxoSmithKline’s failure to adequately research their medication or warn about the risk of congenital malformations. Parents and injured children are filing Zofran birth defect lawsuits throughout the United States who have developed, Cleft Lip, Cleft Palate and severe Heart Defects, especially Atrial Septal Defect and Ventricular Septal Defect.

May 6, 2015

Texas Attorney Explains How Hysterectomy Can Lead to Cancer Spread

by Dr. Shezad Malik

Many product liability lawsuits being filed against the manufacturers of power morcellators. The injured women claim that patients and doctors should have been warned about the risks associated with use of the medical devices during minimally invasive, laparoscopic hysterectomies.

What Are Power Morcellators?

Power morcellators are medical devices that are used during laparoscopic hysterectomy and myomectomy procedures. The device allows the surgeon to grind up the uterus or uterine fibroids and remove the tissue through a small incision in the abdomen. The medical device is used during minimally invasive surgery, and reduces recovery time, scarring and speeds up recovery time.

May 1, 2015

Actos Attorney Explains Bladder Cancer Settlement

by Dr. Shezad Malik

It is official folks, Takeda Pharmaceutical Co. has announced this week, that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agrees to settle more than 9,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.

https://youtu.be/-Zk1JrymY2w

The settlement deal would average about $275,000 for each case, and would be the first settlement in the four year old litigation over the type 2 diabetes drug.

April 29, 2015

Nationwide Actos Bladder Cancer Settlement Confirmed

by Dr. Shezad Malik

Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agreed to settle more than 8,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.

Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. The global settlement will be finalized at the next federal court hearing which is set for May 22.

Actos Settlement Details

April 3, 2015

Does Actos Increase the Risk of Bladder Cancer?

by Dr. Shezad Malik

Rumors are swirling about potential Actos Bladder Cancer settlements. According to Bloomberg News, Takeda Pharmaceutical Co. has indicated that it will pay more than $2.2 billion to settle Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker tentatively agrees to settle more than 8,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.

This potential settlement deal, begs the question; does Actos Increase the Risk of Bladder Cancer? Why would Takeda settle for any amount, if there was no link between Actos and the increased risk of bladder cancer?

Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial currently scheduled in 2016. The first settlement meeting is scheduled next week.

March 25, 2015

Zofran Cleft Lip and Cleft Palate Birth Defect Lawsuits

by Dr. Shezad Malik

Zofran, is an anti-nausea medication that is commonly prescribed for post surgical, chemotherapy and morning sickness patients over the past 20 years. According to experts, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children.

GlaxoSmithKline Allegations

Patients have blamed GlaxoSmithKline’s failure to adequately research their medication or warn about the risk of congenital malformations. Parents and injured children are filing Zofran birth defect lawsuits throughout the United States who have developed, Cleft Lip, Cleft Palate and severe Heart Defects, especially Atrial Septal Defect and Ventricular Septal Defect.

March 24, 2015

Xarelto Bleeding Death Attorney Shares Latest Lawsuit

by Dr. Shezad Malik

As a Dallas Xarelto Bleeding Death attorney and Texas medical doctor, I would like to update my readers about the ongoing status of the Xarelto litigation. Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen.

Danny Julien recently filed a claim in the U.S. District Court for the Eastern District of Louisiana, on behalf of his father, Tommy Julien, who died as a result of uncontrollable bleeding.

According to the personal injury and death lawsuit, Julien suffered from atrial fibrillation and used Xarelto to prevent strokes from the atrial fibrillation. Julien developed severe internal bleeding while on Xarelto, which eventually led to his death.

March 21, 2015

Cook Celect IVC Filter Heart Damage Lawsuit

by Dr. Shezad Malik

Cook Medical is exposed to a personal injury and product liability claim by a Michigan man, who blames the Celect Inferior Vena Cava filter for causing severe injury when it broke apart and punctured his heart.

Larry and Brenda Johnson recently filed a lawsuit in the U.S. District Court for the Eastern District of Michigan, claiming that the filter used to prevent blood clots traveling from the legs to the lungs damaged his heart.

Johnson was implanted with the retrievable IVC filter to prevent blood clots from traveling to his lungs and causing a pulmonary embolism.